Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items

Aligning for growth? The benefits of an EU-UK mutual recognition agreement
Scoping the potential next frontier of a deepening relationship between the UK and the EU.
The wiring behind rewiring the state: Energy devolution in England
How the government can give local leaders the opportunities to lead energy transformation locally.
Devolution that delivers: Fiscal power for regional growth
The UK is one of the most centralised countries in the developed world, and one of the most regionally unequal.